日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects

一项评估呋喹替尼对健康受试者体内 P-gp 和 BCRP 底物药代动力学影响的 1 期研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70408
Gonzalez, Martha; Yang, Zhao; Schelman, William R; Zhou, Xiaofei; Gupta, Neeraj; Chien, Caly
BCR
CRP
发表日期：2025
文献求助 收藏

Assessment of Food Effect and pH-Dependent Drug-Drug Interactions of Fruquintinib in Healthy Subjects

评估食物对健康受试者中呋喹替尼的影响以及pH依赖性药物相互作用

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70168
Gonzalez, Martha; Yang, Zhao; Schelman, William R; Zhou, Xiaofei; Gupta, Neeraj; Chien, Caly
发表日期：2025
文献求助 收藏

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

接受雷莫芦单抗治疗的晚期肝细胞癌的进展模式

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.14731
Reig, Maria; Galle, Peter R; Kudo, Masatoshi; Finn, Richard; Llovet, Josep M; Metti, Andrea L; Schelman, William R; Liang, Kun; Wang, Chunxiao; Widau, Ryan C; Abada, Paolo; Zhu, Andrew X
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

吉西他滨联合TH-302与吉西他滨单药治疗晚期胰腺癌患者的随机II期临床试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2014.55.7504
Borad, Mitesh J; Reddy, Shantan G; Bahary, Nathan; Uronis, Hope E; Sigal, Darren; Cohn, Allen L; Schelman, William R; Stephenson, Joe Jr; Chiorean, E Gabriela; Rosen, Peter J; Ulrich, Brian; Dragovich, Tomislav; Del Prete, Salvatore A; Rarick, Mark; Eng, Clarence; Kroll, Stew; Ryan, David P
胰腺癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors

一项针对难治性实体瘤的γ-分泌酶抑制剂RO4929097联合卡培他滨的多中心I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0166-6
LoConte, Noelle K; Razak, Albiruni R A; Ivy, Percy; Tevaarwerk, Amye; Leverence, Rachael; Kolesar, Jill; Siu, Lillian; Lubner, Sam J; Mulkerin, Daniel L; Schelman, William R; Deming, Dustin A; Holen, Kyle D; Carmichael, Lakeesha; Eickhoff, Jens; Liu, Glenn
发表日期：2015
文献求助 收藏

High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI

利用时间分辨三维径向磁共振成像技术对肝脏进行高空间分辨率和高时间分辨率的动态对比增强灌注成像

期刊:Magnetic Resonance in Medicine
影响因子:3
doi:10.1002/mrm.24727
Brodsky, Ethan K; Bultman, Eric M; Johnson, Kevin M; Horng, Debra E; Schelman, William R; Block, Walter F; Reeder, Scott B
发表日期：2014
文献求助 收藏

A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

一项针对晚期实体瘤患者（包括广泛期小细胞肺癌患者）的AT-101联合顺铂和依托泊苷的I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-013-9999-7
Schelman, William R; Mohammed, Tabraiz A; Traynor, Anne M; Kolesar, Jill M; Marnocha, Rebecca M; Eickhoff, Jens; Keppen, Michael; Alberti, Dona B; Wilding, George; Takebe, Naoko; Liu, Glenn
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏

A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

一项针对晚期实体瘤患者的间歇给药伏立诺他联合硼替佐米的I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-013-0035-8
Deming, Dustin A; Ninan, Jacob; Bailey, Howard H; Kolesar, Jill M; Eickhoff, Jens; Reid, Joel M; Ames, Matthew M; McGovern, Renee M; Alberti, Dona; Marnocha, Rebecca; Espinoza-Delgado, Igor; Wright, John; Wilding, George; Schelman, William R
发表日期：2014
文献求助 收藏

Dynamic tumor growth patterns in a novel murine model of colorectal cancer

新型小鼠结直肠癌模型中的动态肿瘤生长模式

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-13-0163
Paul Olson, Terrah J; Hadac, Jamie N; Sievers, Chelsie K; Leystra, Alyssa A; Deming, Dustin A; Zahm, Christopher D; Albrecht, Dawn M; Nomura, Alice; Nettekoven, Laura A; Plesh, Lauren K; Clipson, Linda; Sullivan, Ruth; Newton, Michael A; Schelman, William R; Halberg, Richard B
肿瘤
肠癌
肿瘤免疫
发表日期：2014
文献求助 收藏

A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study

一项针对晚期胰腺癌和胆道癌患者的索拉非尼、奥沙利铂和2天高剂量卡培他滨I期研究：威斯康星肿瘤网络研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-012-9916-5
LoConte, Noelle K; Holen, Kyle D; Schelman, William R; Mulkerin, Daniel L; Deming, Dustin A; Hernan, Hilary R; Traynor, Anne M; Goggins, Timothy; Groteluschen, David; Oettel, Kurt; Robinson, Emily; Lubner, Sam J
胰腺癌
肿瘤
胆管癌
肿瘤免疫
发表日期：2013
文献求助 收藏